Biomimetic Platinum Nanozyme Immobilized on 2D Metal-Organic Frameworks for Mitochondrion-Targeting and Oxygen Self-Supply Photodynamic Therapy

Zhiguo Gao,Yaojia Li,Yu Zhang,Kaiwu Cheng,Peijing An,Fanghui Chen,Jian Chen,Chaoqun You,Qing Zhu,Baiwang Sun
DOI: https://doi.org/10.1021/acsami.9b14958
IF: 9.5
2019-01-01
ACS Applied Materials & Interfaces
Abstract:Photodynamic Therapy (PDT) as a noninvasive therapy mode has attracted considerable attention in the field of oncotherapy. However, the PDT efficacy is restricted either by tumor hypoxia environment or the inherent properties of photosensitizers (PSs) including bad water solution, photobleaching, and easy aggregation. Herein, we designed and synthesized a new 2D metal-organic framework Sm-TCPP nanosheets by assembling transition metal ion (Sm3+) and PSs (TCPP), on which the catalase (CAT)-mimicking platinum nanozyme were then in situ grown for sufficient oxygen supply during PDT. The prepared Sm-TCPP with nanoplate morphology (~100 nm in diameter) and ultrathin thickness (<10 nm) showed significantly enhanced 1O2 generation capacity due to the improved physicochemical property and the enhanced intersystem crossing from heavy Sm nodes. More importantly, the CAT-mimicking Pt nanozyme on the Sm-TCPP nanosheets could effectively convert over-expressed H2O2 in tumor microenvironment (TME) into O2 to relieve tumor hypoxia. Further, triphenylphosphine (TPP) molecule was introduced to Sm-TCPP-Pt for an mitochondria-targeting and O2 self-supply PDT system. The experimental results in vitro and in vivo based on MCF-7 breast cancer model revealed that Sm-TCPP-Pt/TPP could relieve tumor hypoxia, and the generated ROS nearby intracellular mitochondria significantly induced cell apoptosis. This study offers an engineering strategy to integrate 2D PSs-based MOF and nanozymes into a nanoplatform to surmount the pitfalls of traditional PDT.
What problem does this paper attempt to address?